NovaBay Pharmaceuticals, Inc. (NovaBay) is a biopharmaceutical company. It is focused on addressing the unmet therapeutic needs of the global, topical anti-infective market with two product categories. These include its three commercial products containing Neutrox (its proprietary hypochlorous acid solution), such as, Avenova for the eye care market, NeutroPhase for wound care, and CelleRx for the dermatology market, and its clinical stage Aganocide compounds. Consisting of 0.03% Neutrox, NeutroPhase may be used to cleanse and remove microorganisms from any type of acute or chronic wound, and can be used with any type of wound care modality. Cleansing with Avenova removes microorganisms and debris from the skin on eyelids and lashes without burning or irritation. CelleRx (0.015% Neutrox) is a cleansing solution, which is effective for post laser resurfacing, chemical peels and other cosmetic surgery procedures.